mydia pneumoniae.
The purpose of this study was to evaluate the role of C. pneumoniae in community-acquired pneumonia and to establish its incidence in our area. C. pneumoniae is now known to cause acute respiratory infections, including pneumonia, bronchitis, pharyngitis, and sinusitis [1] [2] [3] [4] . Furthermore, studies have indicated its role in the pathogenesis of bronchial asthma and cardiovascular diseases [5] [6] [7] [8] [9] . In addition, infections may be asymptomatic or associated with only mild symptoms (10, 11] . The data on the prevalence ofantibodies indicate that C. pneumoniae infections are common worldwide and occur more frequently in middle-aged and elderly males than in or vascular endothelial cells in patients with chronic infections; thus, the bacteria and their structural components (lipopolysaccharides) have easy access to circulation. The continuous induction of cytokines by C. pneumoniae may lead to chronic inflammation of the vascular endothelium [13] .
Patients and Methods
Inclusion criteria. During a I-year period from October 1991 to October 1992, we prospectively studied all patients who were admitted to two hospitals (Klinikum Benjamin Franklin, Freie Universitat Berlin and City Hospital, Zehlendorf-Heckeshom, Berlin) because of a diagnosis of pneumonia that was made on the basis of a new and persistent infiltrate on a chest roentgenogram and at least two of the following findings: temperature of~38°C or~36.5°C, leukocytosis (~1O,000 cells/mm 3 ) or leukopenia (~4,000 cells/mm 3 ), purulent sputum, typical physical findings for pneumonia, or culture yielding a typical pathogen causing pneumonia. Patients with active tuberculosis, pulmonary infarction, hospitalization within 10 days before admission, or nosocomial pneumoniã 48 hours after hospitalization were excluded. Previous chest roentgenograms were reviewed for comparison to ensure that the infiltrate was new and persistent. The study protocol was approved by the ethical committee of the Klinikum Benjamin Franklin. carinii infection. There was no culture detection of C. pneumoniae.
Results
Statistical methods. The statistical comparisons were made by means of analysis of Xl contingency tables [19] .
Patients. During our 12-month, prospective, two-center study, we enrolled 296 patients with 297 cases of pneumonia. Each patient fulfilled the inclusion criteria, but retrospective review after days or weeks of follow-up revealed that 60 patients had another disease, such as pulmonary edema, pulmonary infarction, tuberculosis, or tumor. Thus, 236 patients with 237 cases of pneumonia were finally included in the study; the patients were followed for up to 8 weeks after recovery or until death. There were 147 males (62%) and 89 females (38%); the patients' ages ranged from 17 to 94 years (mean age, 57 years). One hundred thirteen patients (48%) were older than 60 years of age.
One hundred eighty-four patients (78%) had one or more significant underlying diseases. Ninety-eight (42%) of these patients had more than two severe diseases. Only fifty-two patients (22%) had a history of being healthy. Cardiovascular disorders were present in 92 patients (39%) and represented the most frequent underlying illness (table 1) . Sixty-three patients (27%) had chronic obstructive pulmonary disease (COPD); a history of bronchitis or recent pneumonia was documented for 50 patients (21 %). Eleven patients (5%) had bronchial asthma. Forty-one patients (17%) were immunocompromised (organ transplantation, 10 patients; therapy for underlying illness, 31 patients). Twenty-four patients (10%) were HIV-positive or had AIDS. Gastrointestinal disorders were present in 39 patients (17%). Thirty-eight patients (16%) had malignant conditions. Diabetes mellitus was present in 34 (14%) of the patients, and 27 (11%) had chronic renal insufficiency.
Results of diagnostic procedures. Despite the availability of extensive clinical and laboratory data with a follow-up rate of 92 (39) 74 (31) 50 (21) 41 (17) 39 (17) 38 (16) 34 (14) 27 (11) performed on the day of admission and during the hospital stay (on the fourth and 10th days of hospitalization and at the end of therapy). The clinical data were stored on a personal computer; data analysis was performed with FLEXDOC (DiplomIngenieur K. Wolfgang Rebel, Berlin) [14] . Furthermore, we collected venous blood samples, respiratory specimens, and urine for bacterial and virological diagnostic tests during the acute stage of illness as well as 2-3 and 6-8 weeks after the onset of illness. Invasive techniques, such as bronchoscopy, lung biopsy, or pleural puncture, were performed only at the discretion of the attending physician and not for purposes of the study.
Microbiological methods. Diagnosis of C. pneumoniae infection was made by microimmunofluorescence (MIF) for IgG and IgM antibodies. We obtained three consecutive serum samples from each patient during admission, 2-3 weeks later, and 6-8 weeks later. The antigen strain AR 39 (Washington Research Foundation, University of Washington, Seattle) was suspended in normal yolk sac in PBS. Binding of rheumatoid factor was inhibited by preabsorption of the IgG antibodies in each sample. A fourfold rise in titer of IgM or IgG antibody in acute-and convalescent-phase sera or a titer ofIgM antibody of~1:16 or IgG antibody of~I: 512 in either acute-or convalescent-phase sera was defined as current infection. Titers of IgG antibody of~1:16 or <1:512 were presumed to be due to past infection with C. pneumoniae.
Each serum specimen obtained during admission, after 2-3 weeks, or after 6-8 weeks was also analyzed by the CF test for antibodies to the following antigens: C. pneumoniae; Mycoplasma pneumoniae; Coxiella burnetii; influenza virus types A and B; parainfluenza virus types 1, 2, and 3; and respiratory syncytial virus. Indirect immunofluorescence was used to detect antibodies to Legionella pneumophila serogroups 1-16, Legionella micdadei, Legionella dumoffii, Legionella gormanii, Legionella jordanis, Legionella hackeliae, Legionella bozemanii serogroups 1 and 2, and Legionella longbeachae serogroups 1 and 2. Urine was tested for Legionella antigens by ELISA at the Robert-Koch-Institut in Berlin. Antibodies to Legionella were produced in rabbits according to the method of Kohler and co-workers [15, 16] with L. pneumophila serogroup 1 organisms (strain Philadelphia 1). Diagnosis of legionnaires' disease was made according to the criteria and classification of the World Health Organization [17] .
Sputum, bronchoalveolar lavage (BAL) fluid, pleural fluid or lung biopsy specimens, and blood samples were cultured, and microorganisms were identified according to standard techniques. Sputum samples were considered representative of infection if < 10 epithelial cells and> 25 neutrophils were identified, in conformity with the criteria of the American Society for Microbiology [18] . In BAL fluid,~10 4 cfu of organisms/ mL was considered to be significant. In addition, every BAL fluid sample was routinely screened for L. pneumophila by direct immunofluorescence (DIF). Microscopy and direct staining of BAL fluid was performed for diagnosis of Pneumocystis em 1996;22 (June) nearly 100% among surviving patients, an etiologic agent could be established in only 160 cases (67.5%). In 77 cases (32.5%), the causative agent remained unclear. A single infectious agent was identified in 138 (86%) of 160 cases; 22 (14%) of 160 patients fulfilled the criteria for infections due to more than one etiologic agent. Concomitant infection occurred in 6 (22%) of the 27 cases of C. pneumoniae infection. For many patients, more than one test was positive for the same or different organisms.
A blood specimen was obtained in 193 cases at the time of admission to the hospital, and culture of 34 (17.6%) of these specimens yielded a pathogen. Bacteremia was significantly associated to a high degree with pneumococcal pneumonia (P < .001). The bacterial isolates included Streptococcus pneumoniae (16) , Staphylococcus aureus (7), other streptococci (3), Haemophilus injluenzae (1), and other gram-negative bacilli (4) . Salmonella enteritidis and Corynebacterium diphtheriae were isolated from two patients and one patient, respectively; these isolates were not thought to be causative agents. Of the 97 BALs performed, 37 (38%) yielded pathogens in significant quantities (~10 4 cfu/mL). The following pathogens were cultured from BAL fluid specimens: P. carinii (12) , S. pneumoniae
and Proteus vulgaris (1).
Pathogens. All acute-and convalescent-phase serum samples were routinely tested for antibodies to C. pneumoniae by MIF and the CF test. The total number of serum samples collected was 588, including those obtained at follow-up visits for detection of seroconversion. Antibodies to C. pneumoniae were detected in 113 (47.7%) of 237 cases. The serodiagnostic criteria of an acute infection with C. pneumoniae as the single etiologic agent were fulfilled in 47 (19.8%) of 237 cases. By clinical and radiographic signs, response to antibiotic therapy, and results of culture of a different microorganism, we finally identified definite C. pneumoniae pneumonia in only 27 (11.4%) of 237 cases.
In 15 (55.6%) of 27 cases, the diagnosis was obtained from analysis of the acute-phase serum sample obtained during admission, and in seven cases (25.9%), significant titers were found in convalescent-phase serum samples 2-3 weeks after admission (table 2) . In addition, in five (18.5%) of 27 cases, the diagnosis finally was established after 6-8 weeks of illness. In nine (33%) of 27 cases, fourfold rises and/or falls in titers of IgM antibody were present, and in two of the nine cases, a fourfold rise in the IgG serum fraction was found. In 20 (74%) of 27 cases, infection was thought to be primary, and in seven (26%) of 27 cases, the diagnostic pattern showed a reinfection as defined by the criteria of Grayston et al. [1] (table 2) . The CF test was not useful in the diagnosis of acute chlamydial infection because it showed significant antibody titers in only two of the 27 cases of proven acute chlamydial pneumonia. In three cases, the titers in the convalescent-phase sera were slightly elevated, but this finding was not useful for the diagnosis of acute infection (table 2) .
Of the 237 cases of community-acquired pneumonia, 30 (12.7%) were due to S. pneumoniae, the most commonly isolated agent ( than in the rest of the year (no cases) (P < .05). These infections were attributed to an epidemic of Qfever in Berlin during this period, which affected at least 80 patients in the local community [20] .
Clinical presentation. In general, the most common clinical manifestations were cough (84% of cases; productive in 68%), fever (79%), shortness ofbreath (71 %), and night sweats (49%). Abnormal physical findings were present in 144 (61 %) of 237 cases. There were no distinctive features in underlying diseases, symptomatology or physical signs, laboratory data, or prognostic factors associated with the five major etiologies (table 4) .
The clinical picture of C. pneumoniae infection was variable. The median age of patients with C. pneumoniae pneumonia was 58.6 years (range, 23-86 years); 11 (41 %) of the patients were older than 60 years of age. More than two-thirds (19 [70%] ) of the patients were male. The average length ofhospital stay for these patients was 19 days; there were no fatalities. Most (25 [93%]) of these patients had chronic underlying diseases.
It was not possible to distinguish clinically or radiographically between C. pneumoniae infection and other etiologically defined pneumonias. However, interstitial infiltration on chest roentgenograms was highly significant for atypical pneumonia due to pathogens such as C. pneumoniae and M. pneumoniae (P < .001). Lobar pneumonia was mainly associated with S. pneumoniae (P < .001) (table 4). Gram-negative bacteria (not including H injiuenzae and Legionella species) were more often isolated from patients older than 70 years of age. Chlamydia and Mycoplasma were rarely recovered from these patients (P < .05).
Mortality. Thirty-four patients (age range, 27-91 years; median age, 64 years) died during hospitalization. The mortality rate of 14.4% was related to age, debilitating disease, and septic shock. All of these patients had one or more underlying disorders (P < .001). The mortality rate was highest among patients infected with gram-negative bacteria other than H. injluenzae and Legionella species (33.3%) and S. pneumoniae (23.3%) and lowest among patients infected with C. pneumoniae (0), Chlamydia psittaci (0), and C. burnetii (0) (P < .01) (table 4).
Discussion
Methods. The prevalence of antibodies to C. pneumoniae in the general population is high worldwide and has varied in the literature from 25% to 77% [21] [22] [23] . The antibodies are frequently present in middle-aged and elderly males, and most people are likely to be infected with C. pneumoniae during their lifetime. Nearly 20% to 30% of patients with sinusitis, otitis media, tonsillitis, laryngitis, and bronchitis have antibodies to C. pneumoniae in their acute-phase sera, and both asymptomatic and chronic infections have been documented by culture [2, 10, 11] . Since symptomatic infections in seronegative patients have also been described, we suggest the use of culture and peR analysis for the detection of C. pneumoniae as routine diagnostic methods for patients with pneumonia [24] . These methods may shed more light on the nature and epidemiology of C. pneumoniae than serology has done to date. Unfortunately, these techniques were not available during our study period.
However, MIF has been described to be highly sensitive and specific for the detection of elementary body antigens of C. pneumoniae, and this method distinguishes between IgM and IgG antibodies [25] , especially if the test is performed on convalescent-phase specimens rather than on single specimens of acute-phase serum. In our study, the diagnosis of acute C. pneumoniae infection could be made by MIF in 55.6% of the cases during admission. In 25.9% of cases, the diagnosis was established after 2-3 weeks, and in 18.5% of cases, late seroconversion was found after 6-8 weeks. In fact, late and regular follow-ups improve diagnostic results when MIF alone is used for the diagnosis of C. pneumoniae infection.
Because our laboratory is experienced in the detection of Chlamydia trachomatis by DIF, culture, and antibody testing, the results ofMIF should be reliable. The positive serum speci-em 1996;22 (June) clonal antibodies or cross-reacting nonchlamydial antigens [27] . The results of the CF test were disappointing, even when acute-and convalescent-phase serum samples were considered together. Seropositivity was found in only two of 27 cases of acute C. pneumoniae infection detected by MIF. Since the CF test is less sensitive than and not as specific as MIF, it was not used for the diagnosis of acute infections. Furthermore, it is not always clear whether bacteria that can colonize the oropharyngeal tract are the genuine cause of observed pneumonia or merely facilitate infection with a second etiologic agent; thus, seroconversion does not necessarily prove the etiology ofpneumoma.
Pathogens. In our community, 19.8% and 47.7% of all patients had serological evidence of current and past C. pneumoniae infection, respectively, although the significance of serological criteria alone may be questioned. Of the 236 patients, 20 (8.4%) had positive titers of IgM or IgG antibodies to C. pneumoniae (indications of acute infection) in serum samples obtained during admission; however, C. pneumoniae was not identified as the causative agent of pneumonia. We concluded that in these cases mild or asymptomatic upper respiratory tract infections were probably induced by Chlamydia and were followed by secondary bacterial pneumonia due to another proven etiology. Males (70.4%) were affected more often than females (29.6%), which corresponds to the findings of other researchers [12] . There was no pathognomonic clinical presentation that would allow the differentiation of C. pneumoniae pneumonia from other types of pneumonia, nor could we serologically confirm the association of C. pneumoniae infection * Haemophilus injfuenzae and Legionella species were excluded because of the significant differences between the patient groups.
with COPD or cardiovascular diseases, as did other investigators [7, 21, 28] . The 1.7% incidence of legionella infection was low but not unusual, because rates from 0 to 16% have been reported in different studies [29] [30] [31] [32] [33] [34] [35] depending on geographic and local conditions. The 8.9% incidence of common infections with gram-negative bacilli (excluding H. influenzae and Legionella species) in all patients was in contrast with the rates in other published reports [36] [37] [38] ; in these studies, more gram-positive pathogens were observed, and gram-negative bacteria were infrequently seen (1%-7% of cases). However, in our study population, 113 patients (48%) were older than 60 years of age and had underlying chronic diseases.
Conclusion
This study describes the microbial etiologies and clinical aspects of community-acquired pneumonia requiring hospitalization, allowing for an updated approach to diagnosis and management. Our data strongly underline the importance of atypical pneumonias, especially those due to C. pneumoniae and M. pneumoniae (which were the most common pathogens of community-acquired pneumonia in our regional area after S. pneumoniae). Pneumonias due to gram-negative pathogens are more common in elderly patients.
Because Chlamydiales organisms have a tendency to cause chronic disease, these results underscore the need for a more rapid, sensitive, specific, inexpensive routine diagnostic method for infection with these pathogens. If MIF is used alone for diagnosis, late convalescent-phase serum samples should be obtained to improve diagnostic results for acute C. pneumoniae infection. Furthermore, a better understanding of the immunopathology associated with reinfection will be important for the development of better therapy for and prevention of chlamydial infection. Physicians should take the high prevalence of these pathogens into consideration when prescribing the initial antibiotic treatment of community-acquired pneumonia.
